Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats. (abst – 2010) http/www.ncbi.nlm.nih.gov/pubmed/19931394
Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3034677/?toolubmed
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24440533
Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3034677/?toolubmed
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24440533